Target intelligence / Profile preview

Alcohol dehydrogenase 4 (class II), pi polypeptide (ADH4)

Target
ADH4
Molecular classification
Enzyme, Oxidoreductase, Medium-chain alcohol dehydrogenase family
01

Overview

Alcohol dehydrogenase 4 (ADH4) is a homodimeric enzyme primarily expressed in the liver that participates in the first step of ethanol metabolism by converting alcohols to aldehydes using NAD(P)+ as a cofactor. It has a broad substrate range, including ethanol, retinol, long-chain aliphatic, and aromatic alcohols, and is uniquely efficient at oxidizing these compared to other alcohol dehydrogenases. Genetically clustered with other ADH genes on chromosome 4, ADH4 appears to have played a role in primate adaptation to terrestrial diets that included fermented fruits. Mutations and variations in ADH4 may contribute to differences in alcohol tolerance, susceptibility to liver disease, and vitamin A metabolism, indicating its biomedical relevance in therapeutics and diagnostics

Other names
Alcohol dehydrogenase 4ADH4ADH2ADH-2Alcohol dehydrogenase 2Alcohol dehydrogenase class II pi chainHEL-S-4All-trans-retinol dehydrogenase [NAD(+)] ADH4Aldehyde reductaseEpididymis secretory protein Li 4
02

Mechanism of action

Catalysis of oxidation of ethanol and other alcohols to their corresponding aldehydes and ketones via NAD(P)+ dependent reactions; Retinol conversion to retinal

03

Biological functions

Ethanol metabolismRetinol metabolismOxidation of long-chain and aromatic alcoholsFatty acid omega-oxidationLipid peroxidation product metabolism
04

Disease associations

Alcohol metabolism disordersLiver diseaseFatty acid metabolism-related conditionsPossibly implicated in vitamin A (retinol) associated conditions
05

Safety considerations

Polymorphisms or deficiencies can lead to altered ethanol metabolism, alcohol intolerance, liver injurySecondary metabolism may produce toxic aldehydes if not further converted (e.g., acetaldehyde)
06

Interacting drugs

Ethanol

2 more in the full profile.

07

Biomarkers

Blood ethanol clearance rates (indirect marker in clinical use)May be assayed in genetic panels for susceptibility to alcoholism and alcohol-related liver disease

Beyond the preview

Go deeper on Alcohol dehydrogenase 4 (class II), pi polypeptide (ADH4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Alcohol dehydrogenase 4 (class II), pi polypeptide (ADH4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call